Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Cash from Investing (Quarterly): -72.65M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -72.65M |
| June 30, 2023 | 55.82M |
| March 31, 2023 | 12.03M |
| December 31, 2022 | -4.113M |
| September 30, 2022 | -26.18M |
| June 30, 2022 | -138.03M |
| March 31, 2022 | -1.122M |
| December 31, 2021 | -0.423M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.015M |
| June 30, 2021 | -0.434M |
| March 31, 2021 | -0.134M |
| December 31, 2020 | -0.001M |
| September 30, 2020 | -0.005M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.005M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-138.03M
Minimum
Jun 2022
55.82M
Maximum
Jun 2023
-11.68M
Average
-0.134M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 92.44M |
| Immunogen Inc (DELISTED) | -1.354M |
| AbbVie Inc | -9.588B |
| Assure Holdings Corp | -0.112M |
| Harpoon Therapeutics Inc (DELISTED) | -1.029M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.97M |
| Cash from Financing (Quarterly) | -0.208M |
| Free Cash Flow | -76.31M |
| Free Cash Flow Per Share (Quarterly) | -0.3798 |
| Free Cash Flow Yield | -11.32% |